Description
CJC-1295 Without DAC Technical Overview
CJC-1295 without DAC is a commercial name commonly used for Modified GRF(1–29), a synthetic analogue of growth hormone-releasing hormone.
Modified GRF(1–29) incorporates selected amino acid substitutions designed to alter peptide stability while retaining activity associated with the GHRH receptor.
Unlike CJC-1295 containing a Drug Affinity Complex, the no-DAC peptide lacks the albumin-binding modification. These compounds should not be treated as chemically identical.
Compound Specifications
| Property | Value |
|---|---|
| Product Name | CJC-1295 Without DAC |
| Common Research Name | Modified GRF(1–29) |
| Classification | Modified GHRH analogue |
| Sequence Length | 29 amino acids |
| Research Receptor | GHRHR |
| DAC Modification | Absent |
| Vial Content | 20mg |
Storage and Handling
- Follow manufacturer storage recommendations.
- Protect from moisture and contamination.
- Maintain appropriate peptide handling procedures.
Lyophilized Format
Modified GRF(1–29) may be supplied in lyophilized form. The exact formulation and stability should follow the manufacturer documentation.
Research Use Disclaimer
CJC-1295 without DAC is not FDA-approved for human therapeutic use. Not intended for human or veterinary administration.
Frequently Asked Questions
What Is CJC-1295 Without DAC?
A commercially named modified GHRH(1–29) analogue lacking the DAC modification.
What Is Modified GRF(1–29)?
A synthetic 29-residue analogue of growth hormone-releasing hormone.
Which Receptor Is Involved?
GHRHR.
What Is the Difference From CJC-1295 With DAC?
The no-DAC compound lacks the chemical albumin-binding modification.
Is It FDA-Approved?
No.
Research Overview
Modified GRF(1–29) is investigated as a chemically modified GHRH analogue.
GHRHR Research
Studies focus on receptor-mediated cellular signaling.
Peptide Stability Research
Selected sequence substitutions are relevant to investigations of peptide degradation and stability.
Growth Hormone Signaling
GHRH receptor activity is studied in relation to pituitary growth hormone regulation.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| GHRHR | Receptor activation assays |
| Peptide Chemistry | Modified sequence analysis |
| Endocrine Research | GHRH signaling measurements |
References
Certificate of Analysis (COA)
Documentation should establish the complete modified GRF(1–29) sequence, salt form, purity, and content. Peptide Lives.
Reviews
There are no reviews yet.